Lenvatinib 10mg capsules
NHS hospitals in England used £24,215,842 of indicative cost of Lenvatinib 10mg capsules in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 5.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenvatinib 10mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenvatinib 10mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £1,604,985 |
| The Royal Marsden Nhs Foundation Trust | £1,324,243 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,281,133 |
| East And North Hertfordshire Nhs Trust | £1,246,550 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,066,877 |
| Barts Health Nhs Trust | £845,435 |
| Sheffield Teaching Hospitals Nhs Trust | £757,539 |
| Nottingham University Hospitals Trust | £736,271 |
| Univ Hpl B/Ham Nhs Foundation Trust | £705,471 |
| Leeds Teaching Hpls Nhs Trust | £682,958 |
The primary-care picture
Lenvatinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenvatinib medicine page.